Search results
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Amgen shares soar on obesity drug optimism By Proactive Investors
Investing.com· 2 hours agoAmgen Inc (NASDAQ:AMGN, ETR:AMG) shares gained almost 13% at about $314 in early trade on Friday...
Amgen: Q1 Earnings Snapshot
Midland Reporter-Telegram· 19 hours agoTHOUSAND OAKS, Calif. (AP) — Amgen Inc. (AMGN) on Thursday reported a first-quarter loss of $113 million, after reporting a profit in the same period a ...
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral...
Benzinga· 8 hours agoAmgen, Inc. AMGN shares rallied over 14% in Thursday’s after-hours trading after the biopharma...
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 7 hours agoRelease Date: May 02, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Amgen Inc
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks...
Benzinga· 1 hour agoLoading... Loading... U.S. stocks were higher, with the Dow Jones index gaining over 400 points on...
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections A
Guru Focus· 1 day agoRevenue: $7.4 billion, up 22% year-over-year, surpassing estimates of $7.435 billion.Net Income: Reported a net loss of $113 million, a significant drop from a
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
Bloomberg· 18 hours agoAmgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early...
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment - Amgen (NASDAQ:AMGN)
Benzinga· 18 hours agoAmgen Inc. AMGN reported first-quarter financial results after the closing bell Thursday. The...
Amgen ‘very encouraged’ by preliminary data from weight-loss-drug trial, as stock jumps
Market Watch· 18 hours agoShares of Amgen Inc. rallied about 13% in the extended session Thursday after the drug manufacturer...